Taiwan FDA registration f9fac7911b60c9947fefb4d38d42e046
錄秘帕斯 G 異常凝血酶原-N標準品組
Taiwan·Risk Class 2·Fujirebio Inc. Sagamihara Facility·Registered Dec 07, 2023 – Dec 07, 2028ActiveRegistration details
- Analysis ID
- f9fac7911b60c9947fefb4d38d42e046
- Customs Code
- DHA05603624008
Company information
- Manufacturer
- Fujirebio Inc. Sagamihara Facility
- Manufacturer Country
- Japan
- Authorized Representative
- Grand Marquis IVD CO., LTD.
Product details
- Intended Use
- 專用於錄秘帕斯 G 異常凝血酶原-N 檢驗試劑 (Lumipulse PIVKA II-N) 之校正試劑組.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1150 Calibrated Products
- Import Information
- QMS/QSD;; 輸入
Dates and status
- Registration Date
- Dec 07, 2023
- Expiry Date
- Dec 07, 2028
About this record
Access comprehensive regulatory information for 錄秘帕斯 G 異常凝血酶原-N標準品組 in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number f9fac7911b60c9947fefb4d38d42e046 and manufactured by Fujirebio Inc. Sagamihara Facility. The authorized representative in Taiwan is Grand Marquis IVD CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices